This invention relates generally to the field of cardiac resuscitation and, more specifically, to the guidance of the administration of cardiopulmonary resuscitation (CPR) by measuring vascular blood flow.
In emergencies and during operative procedures, the assessment of the state of blood flow of the patient is essential for both diagnosis of the problem and determining the appropriate therapy for the problem. The presence of a cardiac pulse in a patient is typically detected by palpating the patient's neck and sensing palpable pressure changes due to the change in the patient's carotid artery volume. When the heart's ventricles contract during a heartbeat, a pressure wave is sent throughout the patient's peripheral circulation system. A carotid pulse waveform rises with the ventricular ejection of blood at systole and peaks when the pressure wave from the heart reaches a maximum. The carotid pulse falls off again as the pressure subsides toward the end of the pulse.
The absence of a detectable cardiac pulse in a patient is a strong indicator of cardiac arrest. Cardiac arrest is a life-threatening medical condition in which the patient's heart fails to provide blood flow to support life. During cardiac arrest, the electrical activity of the heart may be disorganized (ventricular fibrillation), too rapid (ventricular tachycardia), absent (asystole), or organized at a normal or slow heart rate without producing blood flow (pulseless electrical activity).
The form of therapy to be provided to a patient without a detectable pulse depends, in part, on an assessment of the patient's cardiac condition. For example, a caregiver may apply a defibrillation shock to a patient experiencing ventricular fibrillation (VF) or ventricular tachycardia (VT) to stop the unsynchronized or rapid electrical activity and allow a perfusing rhythm to return. External defibrillation, in particular, is provided by applying a strong electric shock to the patient's heart through electrodes placed on the surface of the patient's chest. If the patient lacks a detectable pulse and is experiencing asystole or pulseless electrical activity (PEA), defibrillation cannot be applied and the caregiver may perform cardiopulmonary resuscitation (CPR), which causes some blood to flow in the patient.
Before providing therapy such as defibrillation or CPR to a patient, a caregiver must first confirm that the patient is in cardiac arrest. In general, external defibrillation is suitable only for patients that are unconscious, apneic, pulseless, and in VF or VT. Medical guidelines indicate that the presence or absence of a cardiac pulse in a patient should be determined within 10 seconds. For example, the American Heart Association protocol for cardiopulmonary resuscitation (CPR) requires a healthcare professional to assess the patient's pulse within five to ten seconds. Lack of a pulse is an indication for the commencement of external chest compressions. Assessing the pulse, while seemingly simple on a conscious adult, is the most often failed component of a basic life support assessment sequence, which may be attributed to a variety of reasons, such as lack of experience, poor landmarks, or error in either finding or not finding a pulse. Failure to accurately detect the presence or absence of the pulse will lead to adverse treatment of the patient either when providing or not providing CPR or defibrillation therapy to the patient.
Electrocardiogram (ECG) signals are normally used to determine whether or not a defibrillating shock should be applied. However, certain rhythms that a rescuer is likely to encounter cannot be determined solely by the ECG signal, e.g., pulseless electrical activity. Diagnoses of these rhythms require supporting evidence of a lack of perfusion despite the myocardial electrical activity as indicated by the ECG signal.
Thus, in order for a rescuer to quickly determine whether or not to provide therapy to a patient, it is necessary to develop an integrated system that is quickly and easily able to analyze the patient's pulse, the amount of blood flow, and perhaps the ECG signals in order to correctly determine whether there is any pulsatile flow in the arteries of the patient.
This necessity is particularly dire in situations or systems in which the rescuer is untrained and/or inexperienced person, as is the case with rescuers for which the system described in U.S. Pat. No. 6,575,914 (Rock et al.) is designed. The '914 patent is assigned to the same assignee as the present invention and is hereby incorporated by reference in its entirety. The '914 patent discloses an Automated External Defibrillator (AED) (hereinafter both AEDs and Semi-Automated External Defibrillators—SAEDs—will be referred to jointly as AEDs) which can be used by first-responding caregivers with little or no medical training to determine whether or not to apply defibrillation to an unconscious patient.
The Rock AED has a defibrillator, a sensor pad for transmitting and receiving Doppler ultrasound signals, two sensor pads for obtaining an ECG signal, and a processor which receives and assesses the Doppler and ECG signals in order to determine whether defibrillation is appropriate for the patient (i.e., whether or not there is a pulse) or whether another form of treatment such as CPR is appropriate. The Doppler pad is secured to a patient's skin above the carotid artery to sense the carotid pulse, which is a key indicator of the sufficiency of pulsatile blood flow. Specifically, the processor in the Rock AED analyzes the Doppler signals to determine whether there is a detectable pulse and analyzes the ECG signals to determine whether there is a “shockable rhythm.” See, e.g., FIG. 7 and accompanying description at col. 6, line 60, to col. 7, line 52, in the '914 patent. The determination of a detectable pulse by the processor in the Rock AED is made by comparing the received Doppler signals against a threshold statistically appropriate with the Doppler signals received. Based on the results of these two separate analyses, the processor determines whether or not to advise defibrillation.
If defibrillation is not advised, the defibrillator can advise that CPR be administered to the patient. When the defibrillator is being operated by a medical professional the medical professional will generally administer CPR in the proper manner. However since an automated defibrillator can be operated by a layperson with no medical training, it is desirable that the defibrillator be capable of coaching the layperson rescuer in the proper application of CPR. CPR coaching can be integrated into a defibrillator as described in U.S. Pat. No. 6,125,299 (Groenke et al.), U.S. Pat. No. 6,351,671 (Myklebust et al.) and U.S. Pat. No. 6,306,107 (Myklebust et al.) The '299 and '671 patents both describe a force sensor which is placed on the patient's chest and to which chest compressions are applied. The force sensor is connected to a defibrillator which senses the applied force of the chest compressions and, using the defibrillator's audible prompts, coaches the rescuer to press “harder” or “softer” or “faster” or “slower.” The '107 patent describes a compression pad with an accelerometer instead of a force sensor which senses the depth of the chest compressions rather than their force. This approach is preferable as CPR guidelines are directed to the depth of compression rather than the applied force, which does not always correlate with compression depth due to different chest resistances to CPR compression. These techniques are effective for CPR coaching because their quantification capability is directed to measuring the compression of the chest, which causes the lungs to inflate and deflate, thereby at least partially oxygenating the blood. These techniques do not measure the other intended effect of CPR, which is causing at least some circulation of blood. Inducing blood flow to the heart muscle can increase electrical activity in the heart, increasing the probability that a defibrillating shock will restore normal heart rhythm. Inducing blood flow to the brain can lengthen the time before irreversible brain injury is caused by the heart stoppage. Accordingly it is desirable for a CPR measurement system to provide a measure of blood flow to the brain in addition to lung inflation and deflation.
In accordance with the principles of the present invention an ultrasonic transducer is attached over the carotid artery and used to sense the velocity of blood movement in the carotid artery during the administration of CPR. One or more measures of blood flow are developed from Doppler processing of the ultrasound signals which are used in the guidance of the administration of CPR. In several illustrated examples the blood flow measures are used in conjunction with other measures such as the force or depth of chest compressions, chest impedance, or ECG data to determine and guide effective application of CPR.
In the drawings:
a-2e illustrate different characteristics and configurations of the transducers of an ultrasonic sensor strip.
a-3b illustrate the inclination of the transducers of an ultrasonic sensor strip in accordance with the principles of the present invention.
a illustrates in block diagram form a vital signs monitor and therapy system constructed in accordance with the principles of the present invention.
b illustrates in block diagram form a portion of a vital signs monitor and therapy system with pulse detection and CPR guidance constructed in accordance with the principles of the present invention.
a-6b illustrate one example of sequential operation of the transducers of an ultrasonic sensor strip.
Referring first to
a is a side view of an example of transducers 1-5. In this example it is seen that the top transmitting surfaces 6 of the transducer elements are rounded. In this example the transducer elements are curved with a 25 mm radius of curvature. The rounding of the transmitting surfaces causes the emitted ultrasound to diverge and thereby insonify a greater area of the body, increasing the likelihood that a target vessel will be insonified and preventing any dead zones between the transducer elements. As an alternative to rounding the shape of the transducer a lens may be used above a flat emitting surface to cause the emitted ultrasound to diverge.
b shows electrical connections made to the transducers 1-5. The transmitting surfaces of the transducer elements which face the skin are covered with an electrode 22 which is grounded for safety. Individual electrodes 22 may be formed on the individual elements which are then electrically connected to the connector 20 by way of cable 18. Alternately the electrode 22 may be a continuous sheet of foil or other flexible, conductive material which covers groups or all of the transducer elements. The sides of the elements which face away from the skin surface have signal electrodes 24 on them. Conductors of cable 18 are connected to these electrodes 24 to provide transmit (drive) signals and return received echo signals from the transducer elements.
a shows one example of how the transducer elements of a transducer pair may be positioned in the matrix 12 for improved signal reception. The Doppler ultrasound signal is angle-dependent. When the angle between the direction of the ultrasound beam and the direction of blood flow is 90°, the Doppler signal is at a minimum, and is strongest when the direction of blood flow is directly toward or away from the transducer. Since vessels close to the skin surface 30 such as the carotid artery 32, which is at an average depth in the body of 7 mm, are approximately parallel to the skin surface, a transducer orientation which transmits ultrasound waves normal to the skin surface 30 will have an angle of incidence of approximately 90° to the direction of flow. To reduce the probability of this orthogonal orientation the transducer elements are inclined at a shallow angle as shown in
In the example of
a is a block diagram of a vital signs monitor and therapy system constructed in accordance with the principles of the present invention. A central processing and control unit 160 controls the various functions and components of the system and processes vital signs data. The central processing and control unit executes processing and control algorithms appropriate for the vital signs being monitored and the treatment being carried out by the system. The central processing and control unit may be connected to other devices by wired or wireless LAN connections or Bluetooth connectivity. The central processing and control unit 160 and other electronic components of the system are powered by a power subsystem 162 which may include a battery, a.c. line, power supply, and other power management and control functions. The clinician interacts with the system by means of a user interface 164 which may include elements such as a display, audio input and output, keypads, and a printer. The patient's ECG is monitored and processed by an ECG and processing subsystem 166 which can perform such functions as impedance, ventilation and arrhythmia analysis. The system includes elements for other vital signs measurement and processing 168 such as SPO2, ETCO2, IBP NIBP, and others. The system includes therapy functions 170 such as pacing and defibrillation, high voltage systems, and patient isolation. The performance of CPR is measured by a CPR measurement subsystem 180 as described more fully below.
b illustrates in block diagram form a portion of a vital signs monitor and therapy system which uses a sensor strip 10 to help guide the administration of CPR in accordance with the principles of the present invention. The sensor strip 10 in
The power Doppler signals are coupled to an analysis module 100, included in the CPR measurement subsystem 180, which can analyze the Doppler signals in various ways. In one example the multiplexer 44 selects the signal from a different receive transducer element every 10 msec as described in our U.S. patent application No. 60/583,966 filed Jun. 29, 2004 and now filed as international application IB 2005/052127, the contents of which is incorporated herein by reference. This polling sequence is shown in
The sampling sequence effected by the multiplexer 44 may exhibit any of a number of variations. For instance, if the analysis module senses a decline in the strength of the power Doppler signal from a selected receive element, the multiplexer may be controlled to begin sampling the signals from the receive elements on either side of the selected element to try to find a stronger signal at an adjacent receive element. As
In addition to detecting velocity the period of the Doppler waveform is sensed by detecting the recurring peak velocity over several chest compressions. The periodicity of this rate of recurrence indicates the rate of chest compressions during CPR. As a result of this analysis the rescuer is audibly and/or visually coached to administer CPR properly. For instance, a typical CPR protocol may call for the rescuer to administer 15 compressions at the rate of 100 compressions per minute. If the rate of recurrence sensed by the analysis module is less than this desired rate the analysis module will apply a signal to an audio synthesizer 102 or the display screen to issue a verbal “press faster” instruction. The audio synthesizer will produce an audio signal which is amplified by an amplifier 104 and applied to a loudspeaker 106 which audibly instructs the rescuer to “press faster.” The analysis module will also compare the peak velocity of blood flow during the compressions to a desired minimum blood flow velocity to be attained by each chest compression. For instance a typical peak velocity value is about 1 m/sec. The reference used by the analysis module may be less than this nominal rate and if the desired reference velocity is not being attained the analysis module can issue a “press harder” command through the audio synthesizer and loudspeaker of the user interface 164. A visual display such as a row of LEDs or a graphical display can illustrate visually the strength of the flow signal in absolute or relative terms and/or the position along the row of transducer sensors where the strongest flow signal has been detected.
In addition to detecting the peak velocity and period of the Doppler waves the analysis module may produce other measures of the sufficiency of the blood flow caused by the CPR compressions, such as mean velocity, volume flow rate, pulsation index, and flow index as described in our U.S. patent applications Nos. 60/609,676 filed Sep. 13, 2004, and 60/613,996 filed Sep. 28, 2004, the contents of which are hereby incorporated by reference.
The systems of
The system of
Thus it is seen that the ultrasonic flow information can be used alone to guide CPR, or the flow information used in conjunction with one or more other physiological parameters such as compression force or depth, patient impedance, and ECG to assist in the guidance of CPR. Other physiological parameters such a s blood pressure may also or alternatively be used.
As previously mentioned the sensor strip in the previous examples is adhesively or mechanically attached to the neck of the patient over the carotid artery. It is important that a good acoustic coupling be established between the transducer elements and the skin surface for the reliable transmission and reception of ultrasound signals. This is generally provided by using a hydrophilic adhesive, an acoustic coupling gel over the skin surface opposed by the transducer elements, or a combination of the two. However the acoustic path can be disrupted if the sensor strip should loosen, which can occur through movement of the patient, perspiration or dirt on the skin surface which retards adhesive attachment, or drying out of the adhesive. When this occurs, it is desirable to alert the rescuer or caregiver to the condition so that the problem can be corrected.
The force sensor may comprise any of a number of known sensor technologies. For instance, the force sensor may comprise conductive rubber with electrodes embedded or located on each side of the rubber. The force sensor may be a piezoelectric sensor or it may be a strain gauge. Signals from the strain gauge can be conducted by wires contained in the cable 18 from which they are coupled to the defibrillator. A processor in the defibrillator monitors the force signal and if it drops below an acceptable level, an audible or visual alarm is issued.
It will be appreciated that sensors measuring pressure rather than force may also be used in a constructed device of the present invention.
Another approach to monitoring the acoustic paths of the transducers is to measure the near field reflections from air pockets in the acoustic paths through signal processing. These air pockets will manifest themselves as strong near field echoes in the ultrasound signal. This can only be performed with a receiving transducer however.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/IB2006/054199 | 11/10/2006 | WO | 00 | 5/15/2008 |
Number | Date | Country | |
---|---|---|---|
60737909 | Nov 2005 | US |